Chemically defined and small molecules-based generation of sinoatrial node-like cells

• Published in: Stem cell research & therapy 2022-04, Vol.13 (1), p.158-158, Article 158
• Main Authors: Hou, Xiaojie, Ma, Shuhong, Fan, Wei, Li, Fang, Xu, Miaomiao, Yang, Chao, Liu, Feng, Yan, Ying, Wan, Juyi, Lan, Feng, Liao, Bin
• Format: Article
• Language: English
• Subjects: Acids; Antibodies; Cardiomyocytes; Cell Differentiation; Chemically defined medium; Differentiation; Embryo cells; Embryonic stem cells; Ethylenediaminetetraacetic acid; Fibroblast growth factors; Fibroblast Growth Factors - genetics; Fibroblast Growth Factors - pharmacology; Flow cytometry; Gene expression; Glucose; Glucose - metabolism; Glycogen Synthase Kinase 3 - metabolism; Growth factors; Heart; Human pluripotent stem cells; Immunofluorescence; Induced Pluripotent Stem Cells - metabolism; Kinases; Lactates; Lactic Acid; Mesoderm; Metabolism; Molecular modelling; Myocytes, Cardiac - metabolism; Pacemakers; Phenotypes; Physiological aspects; Pluripotency; Polymerase chain reaction; Protocol; Signal transduction; Signaling pathway; Sinoatrial Node - metabolism; Sinoatrial node-like cells; Small molecule; Stem cells; Wnt protein; Wnt Signaling Pathway; β-Catenin
• ISSN: 1757-6512; 1757-6512
• DOI: 10.1186/s13287-022-02834-y

Existing methods for in vitro differentiation of human pluripotent stem cells (hPSCs) into sinoatrial node-like cells (SANLCs) require complex and undefined medium constituents. This might hinder the elucidation of the molecular mechanisms involved in cardiac subtype specification and prevent translational application. In our study, we aimed to establish a chemically defined differentiation methods to generate SANLCs effectively and stably. We induced human embryonic stem cells (hESCs)/induced PSCs (hiPSCs) to pan-cardiomyocytes by temporal modulation of the WNT/β-catenin (WNT) signaling pathway with GSK3 inhibitor and WNT inhibitor. During cardiac mesoderm stage of the differentiation process, signaling of WNT, retinoid acid (RA), and fibroblast growth factor (FGF) was manipulated by three specific molecules. Moreover, metabolic selection was designed to improve the enrichment of SANLCs. Finally, RT-PCR, immunofluorescence, flow cytometry, and whole cell patch clamp were used to identify the SANLCs. WNT, RA, and FGF signaling promote the differentiation of hPSCs into SANLCs in a concentration- and time window-sensitive manner, respectively. Synergetic modulation of WNT, FGF, and RA signaling pathways enhance the pacemaker phenotype and improve the differentiation efficiency of SANLCs (up to 45%). Moreover, the purification based on lactate metabolism and glucose starvation further reached approximately 50% of SANLCs. Finally, the electrophysiological data demonstrate that cells differentiated with the proposed protocol produce a considerable number of SANLCs that display typical electrophysiological characteristics of pacemaker cells in vitro. We provide an optimized and chemically defined protocol to generate SANLCs by combined modulation of WNT, RA, and FGF signaling pathways and metabolic selection by lactate enrichment and glucose starvation. This chemically defined method for generating SANLCs might provide a platform for disease modeling, drug discovery, predictive toxicology, and biological pacemaker construction.